The allergy immunotherapies market was valued at US$ 1,819.18 million in 2019 and is projected to reach US$ 4,185.89 million by 2027; it is expected to grow at a CAGR of 11.1% from 2020 to 2027.
Allergy immunotherapy, also called desensitization or hypo-sensitization, is a medical treatment focused on several types of allergies. There is a growth in the prevalence of allergies, and conventional treatment interventions, such as pharmacotherapy, have often been found incompetent. Consequently, allergy immunotherapy is growing popularity for curing several types of allergies by increasing immunological tolerance and changing the course of the disease. The allergy immunotherapies market is expected to grow owing to key driving factors such as the increasing prevalence of allergic disorders and technological advancements in sublingual dosage formulations. However, drawbacks associated with the use of allergy immunotherapies and regulatory variations across regions is likely to hamper the growth of the market during the forecast period.
Lucrative Regions for Allergy Immunotherapies Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Allergy Immunotherapies Market: Strategic Insights
Market Size Value in US$ 1,819.18 Million in 2019 Market Size Value by US$ 4,185.89 Million by 2027 Growth rate CAGR of 11.1% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Allergy Immunotherapies Market: Strategic Insights
| Market Size Value in | US$ 1,819.18 Million in 2019 |
| Market Size Value by | US$ 4,185.89 Million by 2027 |
| Growth rate | CAGR of 11.1% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Growing Prevalence of Allergic Disorders
Allergic disorders are the most common problems addressed by primary care physicians and pediatricians; more than 25% of the population in developed countries suffers from allergies. Allergies encompass a spectrum of disorders that are characterized by the development of an overactive immune response to an allergen, resulting in Th2 polarized cytokine response to the allergen and the production of an IgE antibody response.
The growing prevalence of allergic disorders demands allergy immunotherapy, which is a safe and effective treatment against allergens such as pollen, insect molds, and animals, as well as for allergic asthma. In the recent report of the National Health and Nutrition Examination Survey, 54% of the population had positive test responses to one or more allergens. According to the American Academy of Allergy, Asthma & Immunology, allergic rhinitis affects 10–30% of the population, and adverse drug reactions may affect up to 10% of the global population, and nearly 20% of hospitalized patients. As per the data of the National Center for Health Statistics survey carried out in 2018, the number of reported respiratory allergies, food allergies, and skin allergies in the past 12 months was 7.1 million, 4.8 million, and 9.2 million, respectively.
Immunotherapy is a preventive treatment for allergic reactions to substances such as house dust mites, bee venom, and grass pollens. Immunotherapy involves a gradual increase in doses of the allergen or substance to which the patient is allergic. The incremental doses of the allergen cause the immune system to become less sensitive to the substance, probably by inducing the production of a "blocking" antibody; this lowers the allergic symptoms when the substance is encountered in the future. Immunotherapy also reduces the inflammation that characterizes asthma and rhinitis. Allergic disorders are mostly treated with immunotherapy; thus, the growing prevalence of allergic diseases drives the growth of the market
.
Treatment -Based Insights
Global allergy immunotherapies market, based on treatment is segmented into Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT). In 2019, the Subcutaneous Immunotherapy (SCIT) segment held the largest share of the market, by Treatment. However, the Sublingual Immunotherapy (SLIT) segment is expected to grow at the fastest rate during the forecast period.
Global Allergy Immunotherapies Market, by Treatment– 2019 & 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Allergy Type-Based Insights
The global allergy immunotherapies market, based on allergy type was segmented into allergic rhinitis, asthma, food allergy, venom allergy, and others. The allergic rhinitis segment held the highest share of the allergy immunotherapies market in 2019, by allergy type. Moreover, the same segment is anticipated to witness growth at a significant rate during the forecast period, 2020 to 2027.
Distribution Channel -Based Insights
Global allergy immunotherapies market, based on distribution channel is segmented into, hospital pharmacy, retail pharmacy and online pharmacy. In 2019, the hospital pharmacy settings segment held the largest share of the market, by Distribution channel. Moreover, the same pharmacy segment is expected to grow at the fastest rate during the forecast period
Product launches and expansion strategy are commonly adopted by companies to expand their footprint worldwide and meet the growing demand. These strategies are commonly adopted by the market players in order to expand its product portfolio.
The market players operating in the allergy immunotherapies market adopted the strategy of product innovation to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally.
By Treatment
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
By Allergy Type
- Allergic Rhinitis
- Asthma
- Food Allergy
- Venom Allergy
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
Asia Pacific(APAC)
- China
- India
- South Korea
- Japan
- Australia
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
South America (SAM)
- Brazil
- Argentina
Company Profiles
- ALK-Abelló A/S
- AIMMUNE THERAPEUTICS, INC.
- LETIPharma
- Stallergenes Greer
- HAL Allergy B.V
- Johnson and Johnson Services, Inc.
- Anergis
- DBV Technologies
- Dermapharm Holding
- Allergy Therapeutics
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Treatment ; Allergy Type ; Distribution Channel , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The allergy immunotherapy market majorly consists of the players such as ALK-Abelló A/S, AIMMUNE THERAPEUTICS, INC., LETIPharma, Stallergenes Greer, HAL Allergy B.V., Anergis, DBV Technologies, Dermapharm Holding, Allergy Therapeutics, ASIT biotech are among others.
The factors that are driving the growth of the market are increasing prevalence of allergic disorders and rising preference for immunotherapies due to efficacy and cost-effectiveness are expected to boost the growth of the global allergy immunotherapy market.
Allergy Immunotherapy is an allergy treatment process that involves administering small quantities of allergens into your body and then building up doses slowly over some time until the patient develops immunity. Two types of immunotherapy therapies are available in the market, such as subcutaneous immunotherapy (SCIT), also called allergy shots, and sublingual immunotherapy (SLIT). Individuals with symptoms of allergy and do not respond to conventional medical treatments are the potential targets for allergen immunotherapy.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Allergy Immunotherapies Market – By Treatment
1.3.2 Allergy Immunotherapies Market – By Allergy Type
1.3.3 Allergy Immunotherapies Market – By Distribution Channel
1.3.4 Allergy Immunotherapies Market – By Geography
2. Allergy Immunotherapies Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Allergy Immunotherapies Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia-Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South & Central America – PEST Analysis
4.3 Expert Opinion
5. Allergy immunotherapies Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Prevalence of Allergic Disorders
5.1.2 Technological Advancements in Sublingual Dosage Formulations
5.2 Key Market Restraint
5.2.1 Drawbacks Associated with the Use of Allergy Immunotherapy
5.2.2 Regulatory Variations Across Regions
5.3 Key Market Opportunities
5.3.1 Presence of Strong Product Pipeline
5.4 Future Trends
5.4.1 Increasing FDA Approvals for Drugs
5.5 Impact Analysis
6. Allergy Immunotherapies Market – Global Analysis
6.1 Global Allergy Immunotherapies Market Revenue Forecast And Analysis
6.2 Global Allergy immunotherapies market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Allergy Immunotherapies Market Analysis– by Treatment
7.1 Overview
7.2 Allergy Immunotherapies Market Share, By Treatment, 2019 & 2027 (%)
7.3 Subcutaneous Immunotherapy (SCIT)
7.3.1 Overview
7.3.2 Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)
7.4 Sublingual Immunotherapy (SLIT)
7.4.1 Overview
7.4.2 Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)
8. Allergy Immunotherapies Market Analysis– by Allergy Type
8.1 Overview
8.2 Allergy Immunotherapies Market Share, By Allergy Type, 2019 & 2027 (%)
8.3 Allergic Rhinitis
8.3.1 Overview
8.3.2 Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
8.4 Asthma
8.4.1 Overview
8.4.2 Asthma Market Revenue and Forecasts to 2027 (US$ Million)
8.5 Food Allergy
8.5.1 Overview
8.5.2 Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.6 Venom Allergy
8.6.1 Overview
8.6.2 Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.7 Other Allergies
8.7.1 Overview
8.7.2 Others Market Revenue and Forecasts to 2027 (US$ Million)
9. Allergy Immunotherapies Market Analysis– by Distribution Channel
9.1 Overview
9.2 Allergy Immunotherapies Market Share, By Distribution Channel, 2019 & 2027 (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
10. Allergy Immunotherapies Market Analysis And Forecasts To 2027 – Geographical Analysis
10.1 North America: Allergy immunotherapies market
10.1.1 Overview
10.1.2 North America : Allergy immunotherapies market - Revenue and Forecast to 2027 (US$ Million)
10.1.3 North America: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Allergy immunotherapies market, by Country, 2019 & 2027 (%)
10.1.7 US: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1 Europe: Allergy Immunotherapies Market
10.1.1 Overview
10.1.2 Europe: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 Europe: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.4 Europe: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.5 Europe: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.6 Europe: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
10.1.7 Germany: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Germany: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Germany: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 Germany: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 Germany: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.8 France: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 France: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 France: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 France: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 France: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.9 UK: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 UK: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 UK: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 UK: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 UK: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.10 Italy: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.1 Italy: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.2 Italy: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.10.3 Italy: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.10.4 Italy: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.11 Spain: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.1 Spain: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.2 Spain: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.11.3 Spain: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.11.4 Spain: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.2 Asia-Pacific: Allergy Immunotherapies Market
10.2.1 Overview
10.2.2 Asia-Pacific: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Asia-Pacific Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.2.4 Asia-Pacific Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.2.5 Asia-Pacific Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.2.6 Asia-Pacific: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
10.2.7 China: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 China: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Millkion)
10.2.7.2 China Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.2.7.3 China Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.2.7.4 China Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.2.8 Japan: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 Japan: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 Japan Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.2.8.3 Japan Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.2.8.4 Japan Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.2.9 India: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.1 India: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.2 India Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.2.9.3 India Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.2.9.4 India Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.2.10 South Korea: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.1 South Korea: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.2 South Korea Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.2.10.3 South Korea Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.2.10.4 South Korea Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.2.11 Australia: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Australia: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Australia Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.2.11.3 Australia Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.2.11.4 Australia Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3 Middle East & Africa: Allergy immunotherapies market
10.3.1 Overview
10.3.2 Middle East & Africa: Allergy immunotherapies market - Revenue and Forecast to 2027 (US$ Million)
10.3.3 Middle East and Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.3.4 Middle East and Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.3.5 Middle East and Africa Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3.6 Middle East and Africa: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
10.3.7 Saudi Arabia: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.3.7.1 Saudi Arabia: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.3.7.2 Saudi Arabia Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.3.7.3 Saudi Arabia Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.3.7.4 Saudi Arabia Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3.8 UAE: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.3.8.1 UAE: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.3.8.2 UAE Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.3.8.3 UAE Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.3.8.4 UAE Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3.9 South Africa: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.3.9.1 South Africa: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.2 South Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.3.9.3 South Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.3.9.4 South Africa Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.4 South and Central America: Allergy immunotherapies market
10.4.1 Overview
10.4.2 South and Central America: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.4.3 South and Central America Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.4.4 South and Central America Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.4.5 South and Central America Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.4.6 South and Central America: Allergy immunotherapies Market, by Country, 2019 & 2027 (%)
10.4.7 Brazil: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Brazil: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Brazil Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.4.7.3 Brazil Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.4.7.4 Brazil Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.4.8 Argentina: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.1 Argentina: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.2 Argentina Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.4.8.3 Argentina Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.4.8.4 Argentina Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Allergy Immunotherapies Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
12. Allergy Immunotherapies Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 ALK-Abelló A/S
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 AIMMUNE THERAPEUTICS, INC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 LETIPharma
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Stallergenes Greer
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 HAL Allergy B.V.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Johnson and Johnson Services, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Anergis
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 DBV Technologies
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Dermapharm Holding
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Allergy Therapeutics
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 Glossary of Terms
LIST OF TABLES
Table 1. North America Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 3. North America Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 4. US Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 5. US Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 6. US Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 7. Canada Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Europe: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 14. Europe: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 15. Europe: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 16. Germany: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 17. Germany: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 18. Germany: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 19. France: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 20. France: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 21. France: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 22. UK: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 23. UK: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 24. UK: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 25. Italy: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 26. Italy: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 27. Italy: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 28. Spain: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 29. Spain: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 30. Spain: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 31. Asia-Pacific Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 32. Asia-Pacific Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 33. Asia-Pacific Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 34. China Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 35. China Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 36. China Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 37. Japan Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 38. Japan Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 39. Japan Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 40. India Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 41. India Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 42. India Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 43. South Korea Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 44. South Korea Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 45. South Korea Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 46. Australia Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 47. Australia Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 48. Australia Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 49. Middle East and Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 50. Middle East and Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 51. Middle East and Africa Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 52. Saudi Arabia Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 53. Saudi Arabia Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 54. Saudi Arabia Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 55. UAE Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 56. UAE Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 57. UAE Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 58. South Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 59. South Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 60. South Africa Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 61. South and Central America Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 62. South and Central America Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 63. South and Central America Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 64. Brazil Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 65. Brazil Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 66. Brazil Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 67. Argentina Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 68. Argentina Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 69. Argentina Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 1. Organic Developments Done By Companies
Table 2. Inorganic Developments Done By Companies
Table 3. Glossary of Terms, Allergy Immunotherapies Market
LIST OF FIGURES
Figure 1. Allergy Immunotherapies Market Segmentation
Figure 2. Allergy Immunotherapies Market – By Geography
Figure 3. Global Allergy Immunotherapies Market Overview
Figure 4. Subcutaneous Immunotherapy (SCIT) Segment Held Largest Share of Allergy immunotherapies market
Figure 5. Asia-Pacific to Show Remarkable Growth During Forecast Period
Figure 6. Global Allergy Immunotherapies Market, By Geography (US$ Million)
Figure 7. Global Allergy Immunotherapies Market- Leading Country Markets (US$ Million)
Figure 8. Global Allergy Immunotherapies Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia-Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Allergy immunotherapies Market Impact Analysis of Driver and Restraints
Figure 15. Global Allergy Immunotherapies Market – Revenue Forecast And Analysis – 2019- 2027
Figure 16. Global Allergy Immunotherapies Market – By Geography Forecast and Analysis – 2019- 2027
Figure 17. Market Positioning of Key Players
Figure 18. Allergy Immunotherapies Market Share, by Treatment, 2019 & 2027 (%)
Figure 19. Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)
Figure 20. Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)
Figure 21. Allergy Immunotherapies Market Share, by Allergy Type, 2019 & 2027 (%)
Figure 22. Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
Figure 23. Asthma Market Revenue and Forecasts to 2027 (US$ Million)
Figure 24. Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 25. Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 26. Others Market Revenue and Forecasts to 2027 (US$ Million)
Figure 27. Allergy Immunotherapies Market Share, by Distribution Channel, 2019 & 2027 (%)
Figure 28. Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 29. Retail Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 30. Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 31. North America: Allergy immunotherapies market, by Key Country – Revenue (2019) (USD Million)
Figure 32. North America Allergy immunotherapies market Revenue and Forecast to 2027 (USD Million)
Figure 33. North America: Allergy immunotherapies market, by Country, 2019 & 2027 (%)
Figure 34. US: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Canada: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Mexico: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Europe: Allergy Immunotherapies Market, by Key Country – Revenue (2019) (USD Million)
Figure 38. Europe: Allergy Immunotherapies Market Revenue and Forecast to 2027 (USD Million)
Figure 39. Europe: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
Figure 40. Germany: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 41. France: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 42. UK: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 43. Italy: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 44. Spain: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 45. Asia-Pacific: Allergy Immunotherapies Market, by Key Country – Revenue (2019) (USD Million)
Figure 46. Asia-Pacific Allergy Immunotherapies Market Revenue and Forecast to 2027 (USD Million)
Figure 47. Asia-Pacific: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
Figure 48. China: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 49. Japan: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 50. India: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. South Korea: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 52. Australia: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 53. Middle East & Africa: Allergy immunotherapies market, by Key Country – Revenue (2019) (USD Million)
Figure 54. Middle East & Africa Allergy immunotherapies market Revenue and Forecast to 2027 (USD Million)
Figure 55. Middle East and Africa: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
Figure 56. Saudi Arabia: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 57. UAE: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 58. South Africa: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 59. South and Central America: Allergy immunotherapies market, by Key Country – Revenue (2019) (USD Million)
Figure 60. South and Central America Allergy immunotherapies market Revenue and Forecast to 2027 (USD Million)
Figure 61. South and Central America: Allergy immunotherapies Market, by Country, 2019 & 2027 (%)
Figure 62. Brazil: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 63. Argentina: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 64. Impact of COVID-19 Pandemic on allergy immunotherapies market in North American Countries
Figure 65. Impact of COVID-19 Pandemic on allergy immunotherapies market in European Countries
Figure 66. Impact of COVID-19 Pandemic on allergy immunotherapies market in Asia Pacific Countries
Figure 67. Impact of COVID-19 Pandemic on allergy immunotherapies market in Rest of the World
Figure 68. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Allergy Immunotherapies Market
- ALK-Abelló A/S
- AIMMUNE THERAPEUTICS, INC.
- LETIPharma
- Stallergenes Greer
- HAL Allergy B.V.
- Johnson and Johnson Services, Inc.
- Anergis
- DBV Technologies
- Dermapharm Holding
- Allergy Therapeutics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Allergy Immunotherapies Market
Jul 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jul 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jul 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jul 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jul 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)